These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8641643)

  • 41. [Immunosuppressive therapy with antithymocyte globulin and cyclosporine for paroxysmal nocturnal hemoglobinuria].
    Nakasone H; Iijima K; Asano H; Nakamura F; Kida M; Izutsu K; Urabe A; Usuki K
    Rinsho Ketsueki; 2008 Jul; 49(7):498-504. PubMed ID: 18709982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cerebral ischemia as first manifestation of paroxysmal nocturnal hemoglobinuria].
    Tejada J; Hernández-Echebarría L; Sandoval V; Mostaza JL
    Neurologia; 2007 Sep; 22(7):471-4. PubMed ID: 17853967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses.
    Piercy RJ; Swardson CJ; Hinchcliff KW
    J Am Vet Med Assoc; 1998 Jan; 212(2):244-7. PubMed ID: 9448829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recurrent infections, severe neutropenia and neutrophil chemotaxis defect in paroxysmal nocturnal hemoglobinuria].
    González Moraleja J; Rubio Pérez P; Cabello Carro J; García-Casasola G; Alvarez-Sala JL
    An Med Interna; 1994 Oct; 11(10):490-2. PubMed ID: 7865656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Paroxysmal nocturnal hemoglobinuria].
    Ben-Ami H; Edoute Y
    Harefuah; 1998 Feb; 134(3):178-80, 247. PubMed ID: 9662906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does anemia correction by rHuEPO improve uremic cardiopathy?
    Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
    Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
    Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
    Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Paroxysmal nocturnal hemoglobinuria secondary to an extracorpuscular elutable factor (immunoglobulin)].
    Audétat F; Teyssier A; Perrin L; Miescher PA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1507-10. PubMed ID: 4081680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythropoiesis in paroxysmal nocturnal hemoglobinuria.
    Ruvidić R; Biljanović-Paunović L; Pendić S; Mijović A; Bosković D; Pavlović-Kentera V
    Acta Med Iugosl; 1990; 44(5):447-56. PubMed ID: 2077818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A good outcome pregnancy in a patient with paroxysmal nocturnal hemoglobinuria.
    Takagi H; Imai A; Kawabata I; Sumi H; Shiraki S; Tamaya T
    J Med; 1989; 20(2):163-70. PubMed ID: 2769083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid supplementation improves erythropoietin response.
    Pronai W; Riegler-Keil M; Silberbauer K; Stockenhuber F
    Nephron; 1995; 71(4):395-400. PubMed ID: 8587618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].
    Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of paroxysmal nocturnal hemoglobinuria with danazol].
    Yoshimura Y; Nakayama A; Hama H; Oguchi J; Matsuda J; Kamakura M; Kinoshita T; Yamanaka M; Abe T
    Rinsho Ketsueki; 1990 Sep; 31(9):1489-92. PubMed ID: 2246821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 56. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.
    Bosi A; Vannucchi AM; Grossi A; Guidi S; Rafanelli D; Saccardi R; Ferrini PR
    Bone Marrow Transplant; 1991; 7 Suppl 2():87. PubMed ID: 1878736
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experiences in clinical diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)].
    Zhang Z; Go W; Liu E
    Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):540-4. PubMed ID: 8697914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effective combination therapy by recombinant erythropoietin and cepharanthin in a girl with refractory anemia].
    Kitajima H; Anzai K; Kubo M; Hoshi Y; Akatsuka J
    Rinsho Ketsueki; 1994 Jul; 35(7):694-8. PubMed ID: 8065023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.
    Zachee P; Chew SL; Daelemans R; Lins RL
    Am J Nephrol; 1992; 12(3):188-91. PubMed ID: 1415379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.